Format

Send to

Choose Destination
Macromol Biosci. 2013 Dec;13(12):1648-60. doi: 10.1002/mabi.201300288. Epub 2013 Sep 12.

HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.

Author information

1
Institute of Macromolecular Chemistry Academy of Sciences of the Czech Republic, v.v.i., Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.

Abstract

The synthesis, characterization and results of evaluation of the biological behavior of HPMA copolymer conjugates bearing anti-cancer drugs doxorubicin and mitomycin C are described. Two HPMA copolymer carrier types were synthesized: the linear copolymer and the biodegradable high-molecular-weight diblock copolymer containing a degradable disulfide bond. The polymer-drug conjugates incubated in buffers modeling the intracellular environment released the drugs more rapidly than those incubated in bloodstream conditions. Significant in vitro and in vivo antitumor synergistic activity of the conjugates in the treatment of EL-4 T-cell demonstrates their high potential for solid tumor treatment.

KEYWORDS:

HPMA copolymers; Mitomycin C; combination therapy; doxorubicin; tumor treatment

PMID:
24031022
DOI:
10.1002/mabi.201300288
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center